Azione 2342 TRANS GENIC INC.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Trans Genic Inc.

Azioni

2342

JP3635720000

Mercato chiuso - Japan Exchange
Altri mercati azionari
 08:00:00 12/07/2024 		Variaz. 5gg Var. 1 gen.
264 JPY -0,38% Grafico intraday di Trans Genic Inc. +0,76% +1,54%
2023 Trans Genic Inc. (TSE:2342) annuncia un riacquisto di azioni per 300.000 azioni, pari all'1,78% per 100 milioni di yen. CI
2023 Trans Genic Inc. autorizza un Piano di riacquisto. CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!
Registrazione 100% gratuita
Tranche Update on Trans Genic Inc.'s Equity Buyback Plan announced on November 22, 2023.
Trans Genic Inc.'s Equity Buyback announced on November 22, 2023, has closed with 300,000 shares, representing 1.78% for ¥78.62 million.
Tranche Update on Trans Genic Inc.'s Equity Buyback Plan announced on November 22, 2023.
Trans Genic Inc. announces an Equity Buyback for 300,000 shares, representing 1.78% for ¥100 million.
Trans Genic Inc. authorizes a Buyback Plan.
Trans Genic Inc. Reports Earnings Results for the Full Year Ended March 31, 2023
Trans Genic Inc. acquired MASC Co., Ltd.
Eurofins Clinical Testing Lux Holding Sarl entered into a share purchase agreement to acquire GeneticLab Co., Ltd. from Trans Genic Inc. for ¥3.2 billion.
Tranche Update on Trans Genic Inc.'s Equity Buyback Plan announced on August 25, 2021.
Trans Genic Inc.'s Equity Buyback announced on August 25, 2021, has closed with 550,000 shares, representing 3.19% for ¥298.6 million.
Trans Genic Inc. completed the acquisition of Lunapas LLC.
Tranche Update on Trans Genic Inc.'s Equity Buyback Plan announced on August 25, 2021.
Trans Genic Inc. entered into share transfer agreement to acquire Lunapas LLC.
Trans Genic Inc. announces an Equity Buyback for 550,000 shares, representing 3.17% for ¥300 million.
Trans Genic Inc. authorizes a Buyback Plan.
Japan's Nikkei dips on investor caution, Topix buoyed by BOJ talk
Medicinal Chemistry Pharmaceuticals,Co.,Ltd. announced that it has received ¥0.08 million in funding from Trans Genic Inc.
Medicinal Chemistry Pharmaceuticals,Co.,Ltd. announced that it expects to receive ¥0.08 million in funding from Trans Genic Inc.
Trans Genic Inc. announced that it has received ¥17.45 million in funding from Merrill Lynch Japan Securities Co., Ltd., Investment Arm
Trans Genic Inc. announced that it expects to receive ¥17.45 million in funding from Merrill Lynch Japan Securities Co., Ltd., Investment Arm
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione 2342
  4. Notizie Trans Genic Inc.
  5. Altre lingue